iPSC Cell Therapies Market Report – Research, Industry Analysis Reports and Market Demands

Global iPSC Cell Therapies Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of iPSC Cell Therapies by Type
- 1.3.1 Overview: Global iPSC Cell Therapies Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global iPSC Cell Therapies Consumption Value Market Share by Type in 2025
- 1.3.3 Preclinical/Research Stage
- 1.3.4 Clinical Stage
- 1.3.5 Commercial Stage
1.4 Global iPSC Cell Therapies Market by Application
- 1.4.1 Overview: Global iPSC Cell Therapies Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Neurodegenerative Diseases
- 1.4.3 Cardiovascular Diseases
- 1.4.4 Diabetes
- 1.4.5 Other
1.5 Global iPSC Cell Therapies Market Size & Forecast
1.6 Global iPSC Cell Therapies Market Size and Forecast by Region
- 1.6.1 Global iPSC Cell Therapies Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global iPSC Cell Therapies Market Size by Region, (2021-2032)
- 1.6.3 North America iPSC Cell Therapies Market Size and Prospect (2021-2032)
- 1.6.4 Europe iPSC Cell Therapies Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific iPSC Cell Therapies Market Size and Prospect (2021-2032)
- 1.6.6 South America iPSC Cell Therapies Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa iPSC Cell Therapies Market Size and Prospect (2021-2032)

2 Company Profiles

3 Market Competition, by Players

3.1 Global iPSC Cell Therapies Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of iPSC Cell Therapies by Company Revenue
- 3.2.2 Top 3 iPSC Cell Therapies Players Market Share in 2025
- 3.2.3 Top 6 iPSC Cell Therapies Players Market Share in 2025
3.3 iPSC Cell Therapies Market: Overall Company Footprint Analysis
- 3.3.1 iPSC Cell Therapies Market: Region Footprint
- 3.3.2 iPSC Cell Therapies Market: Company Product Type Footprint
- 3.3.3 iPSC Cell Therapies Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global iPSC Cell Therapies Consumption Value and Market Share by Type (2021-2026)
4.2 Global iPSC Cell Therapies Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

5.1 Global iPSC Cell Therapies Consumption Value Market Share by Application (2021-2026)
5.2 Global iPSC Cell Therapies Market Forecast by Application (2027-2032)

6 North America

6.1 North America iPSC Cell Therapies Consumption Value by Type (2021-2032)
6.2 North America iPSC Cell Therapies Market Size by Application (2021-2032)
6.3 North America iPSC Cell Therapies Market Size by Country
- 6.3.1 North America iPSC Cell Therapies Consumption Value by Country (2021-2032)
- 6.3.2 United States iPSC Cell Therapies Market Size and Forecast (2021-2032)
- 6.3.3 Canada iPSC Cell Therapies Market Size and Forecast (2021-2032)
- 6.3.4 Mexico iPSC Cell Therapies Market Size and Forecast (2021-2032)

7 Europe

7.1 Europe iPSC Cell Therapies Consumption Value by Type (2021-2032)
7.2 Europe iPSC Cell Therapies Consumption Value by Application (2021-2032)
7.3 Europe iPSC Cell Therapies Market Size by Country
- 7.3.1 Europe iPSC Cell Therapies Consumption Value by Country (2021-2032)
- 7.3.2 Germany iPSC Cell Therapies Market Size and Forecast (2021-2032)
- 7.3.3 France iPSC Cell Therapies Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom iPSC Cell Therapies Market Size and Forecast (2021-2032)
- 7.3.5 Russia iPSC Cell Therapies Market Size and Forecast (2021-2032)
- 7.3.6 Italy iPSC Cell Therapies Market Size and Forecast (2021-2032)

8 Asia-Pacific

8.1 Asia-Pacific iPSC Cell Therapies Consumption Value by Type (2021-2032)
8.2 Asia-Pacific iPSC Cell Therapies Consumption Value by Application (2021-2032)
8.3 Asia-Pacific iPSC Cell Therapies Market Size by Region
- 8.3.1 Asia-Pacific iPSC Cell Therapies Consumption Value by Region (2021-2032)
- 8.3.2 China iPSC Cell Therapies Market Size and Forecast (2021-2032)
- 8.3.3 Japan iPSC Cell Therapies Market Size and Forecast (2021-2032)
- 8.3.4 South Korea iPSC Cell Therapies Market Size and Forecast (2021-2032)
- 8.3.5 India iPSC Cell Therapies Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia iPSC Cell Therapies Market Size and Forecast (2021-2032)
- 8.3.7 Australia iPSC Cell Therapies Market Size and Forecast (2021-2032)

9 South America

9.1 South America iPSC Cell Therapies Consumption Value by Type (2021-2032)
9.2 South America iPSC Cell Therapies Consumption Value by Application (2021-2032)
9.3 South America iPSC Cell Therapies Market Size by Country
- 9.3.1 South America iPSC Cell Therapies Consumption Value by Country (2021-2032)
- 9.3.2 Brazil iPSC Cell Therapies Market Size and Forecast (2021-2032)
- 9.3.3 Argentina iPSC Cell Therapies Market Size and Forecast (2021-2032)

10 Middle East & Africa

10.1 Middle East & Africa iPSC Cell Therapies Consumption Value by Type (2021-2032)
10.2 Middle East & Africa iPSC Cell Therapies Consumption Value by Application (2021-2032)
10.3 Middle East & Africa iPSC Cell Therapies Market Size by Country
- 10.3.1 Middle East & Africa iPSC Cell Therapies Consumption Value by Country (2021-2032)
- 10.3.2 Turkey iPSC Cell Therapies Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia iPSC Cell Therapies Market Size and Forecast (2021-2032)
- 10.3.4 UAE iPSC Cell Therapies Market Size and Forecast (2021-2032)

11 Market Dynamics

11.1 iPSC Cell Therapies Market Drivers
11.2 iPSC Cell Therapies Market Restraints
11.3 iPSC Cell Therapies Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 iPSC Cell Therapies Industry Chain
12.2 iPSC Cell Therapies Upstream Analysis
12.3 iPSC Cell Therapies Midstream Analysis
12.4 iPSC Cell Therapies Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global iPSC Cell Therapies market size was valued at US$ 10700 million in 2025 and is forecast to a readjusted size of US$ 22260 million by 2032 with a CAGR of 11.2% during review period.
Induced pluripotent stem cell (iPSC) cell therapy is a cutting-edge regenerative medicine technology that uses somatic cells to be converted into pluripotent stem cells through genetic reprogramming technology, and then differentiate into specific types of cells for the treatment of various diseases. This technology allows scientists to generate corresponding cells from the patient's own cells, reducing the risk of immune rejection.
This report is a detailed and comprehensive analysis for global iPSC Cell Therapies market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global iPSC Cell Therapies market size and forecasts, in consumption value ($ Million), 2021-2032
Global iPSC Cell Therapies market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global iPSC Cell Therapies market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global iPSC Cell Therapies market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for iPSC Cell Therapies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global iPSC Cell Therapies market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer(BlueRock Therapeutics), Notch Therapeutics, Evotec Group, Pluristyx, Inc, Cellino, Fate Therapeutics, Allogene Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Century Therapeutics, Resolution Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
iPSC Cell Therapies market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Preclinical/Research Stage
Clinical Stage
Commercial Stage
Market segment by Application
Neurodegenerative Diseases
Cardiovascular Diseases
Diabetes
Other
Market segment by players, this report covers
Bayer(BlueRock Therapeutics)
Notch Therapeutics
Evotec Group
Pluristyx, Inc
Cellino
Fate Therapeutics
Allogene Therapeutics, Inc.
Takeda Pharmaceutical Company Limited
Century Therapeutics
Resolution Therapeutics
Kenai
Garuda Therapeutics
Hebecell
Allele Biotechnology and Pharmaceuticals
Aspen Neurosciencehttps://www.scispot.com/blog/top-innovative-stem-cell-companies-in-the-us
ElevateBio
iCamumo
BeiGene, Ltd
LumiSTAR Biotechnology
Neukio Biotherapeutics
Help Therapeutics
Hopstem Biotechnology Inc.
Nuwacell Biotechnologies Co., Ltd.
ihan Biotech
iRegene
Allife Medicine
CellOrigin
XellSmart bio
ThinkingBioMed
Cell Inspire Bio
Hema Cell
Yuesai BIO
Cytovia
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe iPSC Cell Therapies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of iPSC Cell Therapies, with revenue, gross margin, and global market share of iPSC Cell Therapies from 2021 to 2026.
Chapter 3, the iPSC Cell Therapies competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and iPSC Cell Therapies market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of iPSC Cell Therapies.
Chapter 13, to describe iPSC Cell Therapies research findings and conclusion.

Buy now